Cardiovascular Outcomes in Anthracycline-Related Cardiomyopathy: When a p Value of >0.05 Is a Good Outcome!

JACC Clin Electrophysiol. 2017 Feb;3(2):151-153. doi: 10.1016/j.jacep.2016.10.004. Epub 2016 Nov 30.

¹ Cardio-Oncology Program, University of South Florida Morsani College of Medicine Department of Cardiovascular Sciences and H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
² Cardiac MR PET CT Program, Department of Radiology, Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Cardio-Oncology Program, Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: tneilan@mgh.harvard.edu.

No abstract available

Keywords: anthracycline; arrhythmia; cardiomyopathy; cardiotoxicity; chemotherapy.

Publication types